CpG Island Hypermethylation as a Biomarker for the Early Detection of Lung Cancer

Methods in Molecular Biology

Volumn 1238, Issue , 2015, Pages 141-171

  Kim, Yujin ^a   Kim, Duk Hwan ^a  

^a NONE

Author keywords

Biologic fluid; CpG island; Early detection; Hypermethylation; Lung cancer

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

AGE; ARTICLE; BODY FLUID; BRONCHIAL ASPIRATION PROCEDURE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CPG ISLAND; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA METHYLATION; DOWN REGULATION; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE LOCUS; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; LINEAR DISCRIMINANT ANALYSIS; LUNG CANCER; MICROARRAY ANALYSIS; PRECANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; GENOMICS; LUNG NEOPLASMS;

ANIMALS; CPG ISLANDS; DNA METHYLATION; EARLY DETECTION OF CANCER; GENOMICS; HUMANS; LUNG NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84955337374     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1804-1_8     Document Type: Article

References (95)

1. Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC (2000) Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92:1308–1316.
2. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC (2009) Randomized controlled trials of the effi cacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 115:5007–5017.
3. Johnston WW, Bossen EH (1981) Ten years of respiratory cytopathology at Duke University Medical Center. II. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, with a comparison between cytopathology and histopathology in the typing of lung cancer. Acta Cytol 25:499–505.
4. Sing A, Freudenberg N, Kortsik C, Wertzel H, Klosa B, Hasse J (1997) Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol 41:399–408.
5. Dobler CC, Crawford AB (2009) Bronchoscopic diagnosis of endoscopically visible lung malignancies: should cytological examinations be carried out routinely? Intern Med J 39:806–811.
6. Van't Westeinde SC, van Klaveren RJ (2011) Screening and early detection of lung cancer. Cancer J 17:3–10.
7. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics,. 2012. CA Cancer J Clin 62:10–29.
8. Subramanian J, Simon R (2010) Gene expression- based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102:464–474.
9. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141–196
10. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95:11891–11896.
11. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT (2001) p16 INK4a and histology-specifi c methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 61:3419–3424.
12. Zöchbauer-Müller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, Seidl S, Minna JD, Gazdar AF (2003) Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 107:612–616.
13. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H (2011) Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88:450–457.
14. Buro-Auriemma LJ, Salit J, Hackett NR, Walters MS, Struovici-Barel Y, Staudt MR, Fuller J, Stevenson CS, Hilton H, Ho MW, Crystal RG (2013) Cigarette smoking induces small airway epithelial epigenetic changes withcorresponding modulation of gene expression. Hum Mol Genet 22:4726–4738.
15. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536–540.
16. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP (1998) Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58:5489–5494.
17. Greco SA, Chia J, Inglis KJ, Cozzi SJ, Ramsnes I, Buttenshaw RL, Spring KJ, Boyle GM, Worthley DL, Leggett BA, Whitehal VL (2010) Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer 16:94.
18. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB (1996) Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci U S A 93:11757–11762.
19. Li Q, Jedlicka A, Ahuja N, Gibbons MC, Baylin SB, Burger PC, Issa JP (1998) Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene 16:3197–3202.
20. Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP (2007) Agerelated DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13:3796–3802.
21. Florath I, Butterbach K, Müller H, Bewerunge- Hudler M, Brenner H (2013) Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet 23(5):1186–1201.
22. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, Mangino M, Zhai G, Zhang F, Valdes A, Shin SY, Dempster EL, Murray RM, Grundberg E, Hedman AK, Nica A, Small KS, Dermitzakis ET, MUTHER, McCarthy MI, Mill J, Spector TD, Deloukas P (2012) Epigenome-wide scans identify differentially methylated regions for age and agerelated phenotypes in a healthy ageing population. PLoS Genet 8:e1002629.
23. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954–5958.
24. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62:2370–2377.
25. Honorio S, Agathanggelou A, Schuermann M, Pankow W, Viacava P, Maher ER, Latif F (2003) Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Oncogene 22:147–150.
26. Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM, Chen CY (2003) Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 111:887–895.
27. Destro A, Bianchi P, Alloisio M, Laghi L, Di Gioia S, Malesci A, Cariboni U, Gribaudi G, Bulfamante G, Marchetti A, Bosari S, Infante M, Ravasi G, Roncalli M (2004) K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers. Lung Cancer 44:23–32.
28. Konno S, Morishita Y, Fukasawa M, Shu Y, Wang D, Tanaka R, Minami Y, Iijima T, Noguchi M (2004) Anthracotic index and DNA methylation status of sputum contents can be used for identifying the population at risk of lung carcinoma. Cancer 102:348–354.
29. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA (2005) Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 11:6505–6511.
30. Cirincione R, Lintas C, Conte D, Mariani L, Roz L, Vignola AM, Pastorino U, Sozzi G (2006) Methylation profi le in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested casecontrol study. Int J Cancer 118:1248–1253.
31. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T (2006) Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66:3338–3344.
32. Machida EO, Brock MV, Hooker CM, Nakayama J, Ishida A, Amano J, Picchi MA, Belinsky SA, Herman JG, Taniguchi S, Baylin SB (2006) Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. Cancer Res 66:6210–6218.
33. Georgiou E, Valeri R, Tzimagiorgis G, Anzel J, Krikelis D, Tsilikas C, Sarikos G, DestouniC, Dimitriadou A, Kouidou S (2007) Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev 16:396–402.
34. Hsu HS, Chen TP, Wen CK, Hung CH, Chen CY, Chen JT, Wang YC (2007) Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment. J Pathol 213:412–419.
35. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH (2007) Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 96:1278–1283.
36. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF (2008) Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol Biomarkers Prev 17:995–1000.
37. Baryshnikova E, Destro A, Infante MV, Cavuto S, Cariboni U, Alloisio M, Ceresoli GL, Lutman R, Brambilla G, Chiesa G, Ravasi G, Roncalli M (2008) Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res 14:1913–1919.
38. Hwang SH, Kim KU, Kim JE, Kim HH, Lee MK, Lee CH, LEE SY, Oh T, An S (2011) Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clin Chem Lab Med 49:699–704.
39. Hubers AJ, Heideman DA, Herder GJ, Burgers SA, Sterk PJ, Kunst PW, Smit HJ, Postmus PE, Witte BI, Duin S, Snijders PJ, Smit EF, Thunnissen E (2012) Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer. J Clin Pathol 65:541–545.
40. Leng S, Do K, Yingling CM, Picchi MA, Wolf HJ, Kennedy TC, Feser WJ, Baron AE, Franklin WA, Brock MV, Herman JG, Baylin SB, Byers T, Stidley CA, Belinsky SA (2012) Defi ning a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res 18:3387–3395.
41. Bruse S, Petersen H, Weissfeld J, Picchi M, Willink R, Do K, Siegfried J, Belinsky SA, Tesfaigzi Y (2014) Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res 15:2.
42. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Li W, Decker PA, Jen J, Sidransky D (1999) Molecular detection of tumor cells in bronchoalveolar lavage fl uid from patients with early stage lung cancer. J Natl Cancer Inst 91:332–339.
43. Kersting M, Friedl C, Kraus A, Pankow BW, Schuermann M (2000) Differential frequencies of p16 INK4a promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 18:3221–3229.
44. Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WW, Mao L (2003) Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res 62:351–355.
45. Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH (2004) Tumor-specifi c methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2:2363–2370.
46. Grote HJ, Schmiemann V, Kiel S, Böcking A, Kappes R, Gabbert HE, Sarbia M (2004) Aberrant methylation of the adenomatous polyposis coli promoter 1A in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 110:751–755.
47. Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS (2004) Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 10:2284–2288.
48. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S (2005) Differential DNA hypermethylation of critical genes mediates the stage-specifi c tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11:2466–2470.
49. Schmiemann V, Böcking A, Kazimirek M, Onofre AS, Gabbert HE, Kappes R, Gerharz CD, Grote HJ (2005) Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 11: 7728–7734.
50. Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, Böcking A (2005) Arrant promoter methylation of p16 (INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 116:720–725
51. Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, Flemming N, Seemann S, Distler J, Lewin J, Tetzner R, Weickmann S, Wille U, Liloglou T, Raji O, Walshaw M, Fleischhacker M, Witt C, Filed JK (2010) SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 10:600.
52. van der Drift MA, Prinsen CF, Knuiman GJ, Janssen JP, Dekhuijzen PN, Thunnissen FB (2012) Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy. Chest 141:169–175.
53. Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V, Field JK (2012) Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 40:825–832.
54. Nikolaidis G, Raji OY, Markopoulou S, Gosney JR, Bryan J, Warburton C, Walshaw M, Sheard J, Field JK, Liloglou T (2012) DNA methylation biomarkers offer improved diagnostic effi ciency in lung cancer. Cancer Res 72:5692–5701.
55. Esteller M, Sanchez-Cespedes M, Rosell M, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67–70.
56. Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G (2002) p16(INK4A) hypermethylation detected by fl uorescent methylation- specifi c PCR in plasmas from non-small cell lung cancer. Clin Cancer Res 8:3782–3787.
57. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D (2003) Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 62:371–375.
58. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M (2005) Identifi cation of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 11:1219–1225.
59. Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M (2008) Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Carcinogenesis 29:1845–1849.
60. Hoffmann AC, Kaifi JT, Vallböhmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Hölscher AH, Schneider PM, Metzger R, Brabender J (2009) Lack of prognostic signifi - cance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. J Surg Oncol 100:414–417.
61. Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D (2010) Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specifi c PCR. Clin Cancer Res 16:3463–3472.
62. Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D (2011) An epigenetic marker panel for detection of lung cancer using cell- free serum DNA. Clin Cancer Res 17:4494–4503.
63. Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L (2011) Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 303:21–28.
64. Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, Field JK, Dietrich D (2011) SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6:1632–1638.
65. Licchesi JD, Westra WH, Hooker CM, Herman JG (2008) Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 14:2570–2578.
66. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, Schübeler D (2007) Distribution, silencing potential and evolutionary impack of promoter DNA methylation in the human genome. Nat Genet 39:457–466.
67. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure Dna methylation. Nucleic Acids Res 28:E32.
68. Irizarry RA, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg SA, Jeddeloh JA, Wen B, Feinberg AP (2008) Comprehensive highthroughput arrays for relative methylation (CHARM). Genome Res 18:780–790
69. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D (2005) Chromosome-wide and promoter-specifi c analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37:853–862.
70. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gräf S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Bäckdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJ, Durbin R, Tavaré S, Beck S (2008) A Bayesian deconvolution strategy for immunoprecipitation- based DNA methylome analysis. Nat Biotechnol 26:779–785.
71. Brinkman A, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg H (2010) Whole-genome DNA methylation profi ling using MethylCap-seq. Methods 52:232–236.
72. Hodges E, Smith AD, Kendall J, Xuan Z, Ravi K, Rooks M, Zhang MQ, Ye K, Bhattacharjee A, Brizuela L, McCombie WR, Wigler M, Hannon GJ, Hicks JB (2009) High defi nition profi ling of mammalian Dna methylation by array capture and single molecule bisulfi te sequencing. Genome Res 19:1593–1605.
73. Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R (2005) Reduced representation bisulfi te sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res 33:5868–5877.
74. Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, Thu KL, Solis LM, Nunez MI, Behrens C, Yee J, English J, Murray N, Tsao MS, Minna JD, Gazdar AF, Wistuba II, MacAulay CE, Lam S, Lam WL (2012) Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PLoS One 7:e37775.
75. Carvalho RH, Haberle V, Hou J, van Gent T, Thongjuea S, van Ijcken W, Kockx C, Brouwer R, Rijkers E, Sieuwerts A, Foekens J, van Vroonhoven M, Aerts J, Grosveld F, Lenhard B, Philipsen S (2012) Genome-wide DNA methylation profi ling of non-small cell lung carcinomas. Epigenetics Chromatin 5:9.
76. Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, Müllauer L, Dekan G, Grin Y, Lang G, End-Pfützenreuter A, Steiner I, Zehetmayer S, Döme B, Arns BM, Fong KM, Wright CM, Yang IA, Klepetko W, Posch M, Zielinski CC, Zöchbauer-Müller S (2013) Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 34:513–521.
77. Sato T, Arai E, Kohno T, Tsuta K, Watanabe S, Soejima K, Betsuyaku T, Kanai Y (2013) DNA methylation profi les at precancerous stages associated with recurrence of lung adenocarcinoma. PLoS One 8:e59444.
78. Sun S, Huang YW, Yan PS, Huang THM, Lin S (2011) Preprocessing differential methylation hybridization microarray data. BioData Min 4:13.
79. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, Lehrach H, Herwig R, Adjaye J (2010) Computational analysis of genome- wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res 20:1441–1450.
80. Huang J, Renault V, Sengenès J, Touleimat N, Michel S, Lathrop M, Tost J (2012) MeQA: a pipeline for MeDIP-seq data quality assessment and analysis. Bioinformatics 28: 587–588.
81. Lienhard M, Grimm C, Morkel M, Herwig R, Chavez L (2013) MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics 30(2):284–286.
82. Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, Johnson CS, Smiraglia DJ, Liu S (2012) IMA: an R package for high- throughput analysis of Illumina’s 450K Infi nium methylation data. Bioinformatics 28:729–730.
83. Touleimat N, Tost J (2012) Complete pipeline for Infi nium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 4:325–341.
84. Maksimovic J, Gordon L, Oshlack A (2012) SWAN: subset-quantile within array normalization for Illumina Infi nium Human-Methylation450 BeadChips. Genome Biol 13:R44.
85. Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S (2013) ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. doi: 10.1093/ bioinformatics/btt684.
86. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infi nium 450k DNA methylation data. Bioinformatics 29:189–196.
87. Zhang Y, Liu H, Lv J, Xiao X, Zhu J, Liu X, Su J, Li X, Wu Q, Wang F, Cui Y (2011) QDMR: a quantitative method for identifi cation of differentially methylated regions by entropy. Nucleic Acids Res 39:e58.
88. Hansen KD, Langmead B, Irizarry RA (2012) BSmooth: from whole genome bisulfi tesequencing reads to differentially methylated regions. Genome Biol 13:R83.
89. Hastie T, Tibshirani R, Friedman J (2005) The elements of statistical learning: data mining, inference and prediction. Springer, New York.
90. Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182.
91. Kohavi R, John GH (1997) Wrapper for feature subset. Artif Intell 97:273–324.
92. Dayhoff JE, DeLeo JM (2001) Artifi cial neural networks: opening the black box. Cancer 91:1615–1635.
93. Guyon I, Weston J, Barnhill S, Vapnik V (2002) Gene selection for cancer classifi cation using support vector machine. Mach Learn 46:389–422.
94. Vapnik V (2000) The nature of statistical learning theory. Springer, New York.
95. Breiman L (2001) Random forests. Mach Learn 45:5–32